title: Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy.
abstract: BACKGROUND
  Isoniazid (INH) is an effective treatment for tuberculosis and among the most common causes of drug-induced seizures in the United States. Isoniazid intoxication produces a characteristic clinical syndrome including seizures, metabolic acidosis, and, in severe cases, respiratory depression and coma.
  
  
  METHODS
  A 10-month-old male infant was presented after being found with his father's INH. The patient was brought to a local hospital where he had a witnessed generalized seizure and was given 650 mg pyridoxine intravenously, which was based on a 70 mg/kg recommendation. Five hours after the time of ingestion, the patient developed recurrent generalized seizures. He was given diazepam and then loaded with phenobarbital 20 mg/kg, while awaiting more pyridoxine from the pharmacy. He received an additional 2 g pyridoxine for a suspected ingestion of approximately 2.7 g INH (290 mg/kg total dose), and his seizures subsequently resolved.
  
  
  CONCLUSIONS
  Treatment of INH toxicity must address correction of gamma-aminobutyric acid deficiency with pyridoxine replacement and management of life-threatening events. For poisonings in which the amount of INH ingested is known, pyridoxine is dosed on a gram-for-gram basis. Several reference textbooks recommend pyridoxine dosing in children to be 70 mg/kg. This was the justification for the initial pyridoxine dose administered in our case. However, after review of the referenced literature, the rationale supporting this recommendation remains unclear. Benzodiazepines should also be given with pyridoxine as they have been shown to have a synergistic effect in terminating seizures in animal models.
  
  
  CONCLUSIONS
  As soon as possible after INH overdose is suspected or diagnosed, pyridoxine should be administered in a dose approximately equal to the estimated amount of INH ingested regardless of the age of the patient.
authors.affiliation: Division of Medical Toxicology, Department of Emergency Medicine, University of California, Rady Children's Hospital, San Diego, CA, USA. abminns01@yahoo.com
authors.forename: Alicia B
authors.initials: AB
authors.lastname: Minns
authors.forename: Nazli
authors.initials: N
authors.lastname: Ghafouri
authors.forename: Richard F
authors.initials: RF
authors.lastname: Clark
mesh_terms: D000995:Antitubercular Agents / Q000506:poisoning*; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D062787:Drug Overdose; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D007538:Isoniazid / Q000506:poisoning*; D008297:Male; D011736:Pyridoxine / Q000008:administration & dosage* / Q000009:adverse effects; D013226:Status Epilepticus / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D014803:Vitamin B Complex / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000995:Antitubercular Agents; D014803:Vitamin B Complex; D011736:Pyridoxine; D007538:Isoniazid